Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Total Debt (2016 - 2020)

Cardiff Oncology's Total Debt history spans 7 years, with the latest figure at $234270.0 for Q2 2020.

  • For Q2 2020, Total Debt changed N/A year-over-year to $234270.0; the TTM value through Jun 2020 reached $234270.0, changed N/A, while the annual FY2017 figure was $1.3 million, 91.95% down from the prior year.
  • Total Debt for Q2 2020 was $234270.0 at Cardiff Oncology, down from $1.2 million in the prior quarter.
  • Across five years, Total Debt topped out at $16.6 million in Q1 2017 and bottomed at $234270.0 in Q2 2020.
  • The 4-year median for Total Debt is $8.4 million (2016), against an average of $8.7 million.
  • The largest annual shift saw Total Debt grew 7.61% in 2016 before it tumbled 92.91% in 2018.
  • A 4-year view of Total Debt shows it stood at $16.5 million in 2016, then tumbled by 91.95% to $1.3 million in 2017, then dropped by 11.76% to $1.2 million in 2018, then plummeted by 80.06% to $234270.0 in 2020.
  • Per Business Quant, the three most recent readings for CRDF's Total Debt are $234270.0 (Q2 2020), $1.2 million (Q1 2018), and $1.3 million (Q4 2017).